Literature DB >> 2839859

Corticotropin and cortisol response to human CRH as a probe for HPA system integrity in major depressive disorder.

K P Lesch1, G Laux, H M Schulte, H Pfüller, H Beckmann.   

Abstract

To explore the integrity of the hypothalamic-pituitary-adrenal (HPA) system in major depressive disorder, 12 patients and normal controls matched for sex, age, and body weight received 100 micrograms synthetic human corticotropin-releasing hormone (hCRH) as an i.v. bolus dose. Compared to controls, depressed patients showed an elevation in baseline cortisol and a significant attenuation of net adrenocorticotropin (ACTH) responses, while cortisol secretion in response to hCRH was normal. These abnormalities in HPA axis function and apparent discordances in the interrelationships of ACTH and cortisol baseline and net stimulation responses between depressed patients and normal controls indicate, at least in part, a derangement of the glucocorticoid-dependent negative feedback circuitry and support the hypothesis that HPA hyperactivity in depression involves neurotransmitter-mediated hypothalamic hypersecretion of CRH.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839859     DOI: 10.1016/0165-1781(88)90136-9

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  10 in total

1.  Acute and chronic effects of the atypical antidepressant, mianserin on brain noradrenergic neurons.

Authors:  A L Curtis; R J Valentino
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 2.  The 5-HT receptor--G-protein--effector system complex in depression. I. Effect of glucocorticoids.

Authors:  K P Lesch; B Lerer
Journal:  J Neural Transm Gen Sect       Date:  1991

Review 3.  Dissection of glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis by gene targeting in mice.

Authors:  Gloria Laryea; Lisa Muglia; Melinda Arnett; Louis J Muglia
Journal:  Front Neuroendocrinol       Date:  2014-09-27       Impact factor: 8.606

Review 4.  Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity.

Authors:  F Holsboer
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

Review 5.  Psychoneuroendocrine research in depression. I. Hormone levels of different neuroendocrine axes and the dexamethasone suppression test.

Authors:  R Rupprecht; K P Lesch
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

6.  The influence of human corticotropin-releasing hormone on somatostatin secretion in depressed patients and controls.

Authors:  K P Lesch; E Widerlöv; R Ekman; G Laux; R Rupprecht; H M Schulte; H Beckmann
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

Review 7.  Exercise and the treatment of clinical depression in adults: recent findings and future directions.

Authors:  Alisha L Brosse; Erin S Sheets; Heather S Lett; James A Blumenthal
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 8.  Suggested Biomarkers for Major Depressive Disorder.

Authors:  Yunus Hacimusalar; Ertuğrul Eşel
Journal:  Noro Psikiyatr Ars       Date:  2018-05-28       Impact factor: 1.339

9.  The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models.

Authors:  B T Baune; M Stuart; A Gilmour; H Wersching; W Heindel; V Arolt; K Berger
Journal:  Transl Psychiatry       Date:  2012-03-13       Impact factor: 6.222

10.  Depression following hip fracture is associated with increased physical frailty in older adults: the role of the cortisol: dehydroepiandrosterone sulphate ratio.

Authors:  Anna C Phillips; Jane Upton; Niharika Arora Duggal; Douglas Carroll; Janet M Lord
Journal:  BMC Geriatr       Date:  2013-06-17       Impact factor: 3.921

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.